Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose arabinosyl cytosine. 1985

M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001855 Bone Marrow Diseases Diseases involving the BONE MARROW. Bone Marrow Disease,Disease, Bone Marrow,Diseases, Bone Marrow,Marrow Disease, Bone,Marrow Diseases, Bone
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
January 1983, Leukemia research,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
January 1985, Leukemia research,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
January 1985, Haematology and blood transfusion,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
October 1985, American journal of hematology,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
June 1987, Japanese journal of clinical oncology,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
April 1984, Blut,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
August 1984, Ugeskrift for laeger,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
February 1996, Journal of pediatric hematology/oncology,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
November 1984, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
M Baccarani, and G Fasola, and R Fanin, and P Morassi, and M Florean, and G Pozzato, and G Cavazzini, and A Zaccaria, and L Guarini, and L Lodi
January 1987, Haematology and blood transfusion,
Copied contents to your clipboard!